<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>2VIQ</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>Journal of Medicinal Chemistry</Publication><Title>Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator &amp;#8224;</Title><Author>Frederickson, Martyn</Author><Author>Callaghan, Owen</Author><Author>Chessari, Gianni</Author><Author>Congreve, Miles</Author><Author>Cowan, Suzanna R.</Author><Author>Matthews, Julia E.</Author><Author>McMenamin, Rachel</Author><Author>Smith, Donna-Michelle</Author><Author>VinkovicÃÅ, Mladen</Author><Author>Wallis, Nicola G.</Author><Publisher>American Chemical Society</Publisher><PublicationYear>2008</PublicationYear><DOI>10.1021/jm701359z</DOI><Volume>51</Volume><Issue>2</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Urokinase-type plasminogen activator</ChemicalName><MacroMoleculeClass>HYDROLASE</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>28875.85</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>RIGAKU RUH3R RIGAKU CCD</Equipment><Description>Data collection temperature: 93.0 K, Resolution: 2.0</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL</Sequence><SpaceGroup>P 21 21 21</SpaceGroup><pH>6.6</pH></Biological></PROPERTIES></PolymerNanocomposite>